PMID,Journal,publisher_guess,year,doi,doi_url
38196672,J Adv Pract Oncol,Unknown,2023,10.6004/jadpro.2023.14.7.4,"https://www.advancedpractitioner.com/issues/volume-14,-number-7-(novdec-2023)/characterization-and-management-of-adverse-reactions-in-patients-with-unresectable-hepatocellular-carcinoma-treated-with-lenvatinib.aspx"
37206906,J Adv Pract Oncol,Unknown,2023,10.6004/jadpro.2023.14.3.15,"https://www.advancedpractitioner.com/cme-supplements/volume-14,-number-1-(apr-2023)/revolutionizing-cancer-treatment-harnessing-the-power-of-biomarkers-to-improve-patient-outcomes.aspx"
